{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:02:58Z","timestamp":1767135778435,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009136","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000}}],"reference-count":41,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009136.pub2","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T17:26:47Z","timestamp":1364578007000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methods for administering subcutaneous heparin during pregnancy"],"prefix":"10.1002","volume":"2013","author":[{"given":"Hatoko","family":"Sasaki","sequence":"first","affiliation":[{"name":"National Center for Child Health and Development; Department of Health Policy; 2-10-1 Okura, Setagaya Tokyo Tokyo Japan 157-8535"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Yonemoto","sequence":"additional","affiliation":[{"name":"Translational Medical Center, National Center of Neurology and Psychiatry; Department of Epidemiology and Biostatistics; 4-1-1 Ogawahigashimachi Kodaira Tokyo Japan 187-8553"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutsugu","family":"Hanada","sequence":"additional","affiliation":[{"name":"National Center for Child Health and Development; Department of Health Policy; 2-10-1 Okura, Setagaya Tokyo Tokyo Japan 157-8535"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Mori","sequence":"additional","affiliation":[{"name":"National Center for Child Health and Development; Department of Health Policy; 2-10-1 Okura, Setagaya Tokyo Tokyo Japan 157-8535"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"10.1002\/14651858.CD009136.pub2-BIB0002|cit1","first-page":"678","article-title":"The use of an indwelling teflon catheter for subcutaneous heparin administration during pregnancy: a randomized crossover study","volume":"270","author":"Anderson","year":"1993","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD009136.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archinte.1993.00410070035005","article-title":"The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study","volume":"153","author":"Anderson","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Bank I Libourel EJ Middeldorp S Van Der Meer J Buller HR High rate of skin complications due to low-molecular-weight heparins in pregnant women Journal of Thrombosis and Haemostasis 2003 859 61","DOI":"10.1046\/j.1538-7836.2003.t01-7-00115.x"},{"issue":"6","key":"10.1002\/14651858.CD009136.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0002-9378(95)90443-3","article-title":"Heparin levels to guide thromboembolism prophylaxis during pregnancy","volume":"173","author":"Barbour","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD009136.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0020-7292(01)00535-5","article-title":"ACOG practice bulletin. Thrombembolism in pregnancy","volume":"75","author":"Barbour","year":"2001","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD009136.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009136.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD009136.pub2-BIB0009|cit9","first-page":"1237","article-title":"Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women","volume":"98","author":"Bauersachs","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009136.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"20","key":"10.1002\/14651858.CD009136.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009136.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/deh115","article-title":"Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control","volume":"19","author":"Carlin","year":"2004","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1160\/TH08-08-0526","article-title":"Venous thromboembolism in pregnancy: diagnosis, management and prevention","volume":"101","author":"Chunilal","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009136.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","article-title":"Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin","volume":"168","author":"Dahlman","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","article-title":"Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies","volume":"87","author":"Dulitzki","year":"1996","journal-title":"Obstetrics & Gynecology"},{"issue":"7109","key":"10.1002\/14651858.CD009136.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD009136.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.159.11.1221","article-title":"Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery","volume":"159","author":"Etchells","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0018|cit18","volume-title":"Harrison's Principles of Internal Medicine","author":"Fauci","year":"2008"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD009136.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0002-9378(91)90442-T","article-title":"Administration of heparin by subcutaneous infusion with a programmable pump","volume":"165","author":"Floyd","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD009136.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-136-2-200201150-00006","article-title":"Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging","volume":"136","author":"Fraser","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009136.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD009136.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy. Risks to the fetus and mother","volume":"149","author":"Ginsberg","year":"1989","journal-title":"Archives of Internal Medicine"},{"issue":"5 Supp","key":"10.1002\/14651858.CD009136.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"524S","DOI":"10.1378\/chest.114.5_Supplement.524S","article-title":"Use of antithrombotic agents during pregnancy","volume":"114","author":"Ginsberg","year":"1998","journal-title":"Chest"},{"issue":"20","key":"10.1002\/14651858.CD009136.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0025|cit25","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD009136.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis","volume":"306","author":"Hull","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"27","key":"10.1002\/14651858.CD009136.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198212303072704","article-title":"Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis","volume":"307","author":"Hull","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0028|cit28","first-page":"187","article-title":"Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy","volume":"3","author":"James","year":"2005","journal-title":"Clinical Advances in Hematology & Oncology"},{"issue":"5","key":"10.1002\/14651858.CD009136.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semperi.2007.03.002","article-title":"Thromboembolism in pregnancy: recurrence and its prevention","volume":"31","author":"James","year":"2007","journal-title":"Seminars in Perinatology"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2009.1.277","article-title":"Pregnancy-associated thrombosis","volume":"1","author":"James","year":"2009","journal-title":"Hematology"},{"issue":"3","key":"10.1002\/14651858.CD009136.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0b013e3182310c4c","article-title":"Practice bulletin no. 123: thromboembolism in pregnancy","volume":"118","author":"James","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"19","key":"10.1002\/14651858.CD009136.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMra0707993","article-title":"Current concepts: venous thromboembolic disease and pregnancy","volume":"359","author":"Marik","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009136.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Nijkeuter M Huisman MV Diagnosing pulmonary embolism in pregnancy: Is there a role for D-dimer as a stand-alone test? Critical Care Medicine 2006 2701; author reply 2701-2","DOI":"10.1097\/01.CCM.0000239437.16274.4F"},{"issue":"4","key":"10.1002\/14651858.CD009136.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0037|cit37","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) Reducing the risk of thrombosis and embolism during pregnancy and the puerperium Green-top Guideline Number 37 2009"},{"key":"10.1002\/14651858.CD009136.pub2-BIB0038|cit38","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"1","key":"10.1002\/14651858.CD009136.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0020-7292(00)00290-3","article-title":"Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin","volume":"71","author":"Rey","year":"2000","journal-title":"International Jounal of Gynecology & Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD009136.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajog.2005.07.044","article-title":"Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section","volume":"194","author":"Rodger","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD009136.pub2-BIB0041|cit41","first-page":"1307","article-title":"A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy","volume":"101","author":"Sephton","year":"2003","journal-title":"Obstetrics & Gynecology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009136.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T07:32:17Z","timestamp":1737617537000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009136.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009136.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}